ILUMYA® (tildrakizumab-asmn) - ILUMYA® Patient Stories

Bruce Sands, MD: Efficacy of Mirikizumab for UC Treatment in LUCENT-1 Trial

Best Psoriasis Treatments: Creams, Ointments, and Medications - GoodRx

FDA approves Lilly's Omvoh for Crohn's disease

Eli Lilly Reports Data From Phase 2 SERENITY Study Evaluating Mirikizumab

Patient Reported Outcomes From Clinical Trials to Clinical Practice and Vice-Versa: Lessons Learnt from Global PROMS Initiative

Efficacy and Safety of Mirikizumab as Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From The Phase 3 LUCENT-2 Study